Trial Profile
A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs IMR-261 (Primary)
- Indications Acute kidney injury
- Focus Adverse reactions
- Sponsors Complexa
- 12 Nov 2015 According to Complexa media release, status changed from recruiting to completed.
- 04 Jun 2015 New trial record